Yson Sharon C, Sembrano Jonathan N, Santos Edward Rainier G
Department of Orthopaedic Surgery, University of Minnesota Medical Center, 2450 Riverside Ave S R200, Minneapolis, MN 55454, United States.
Department of Orthopaedic Surgery, University of Minnesota Medical Center, 2450 Riverside Ave S R200, Minneapolis, MN 55454, United States.
J Clin Neurosci. 2017 Apr;38:118-121. doi: 10.1016/j.jocn.2016.12.037. Epub 2017 Jan 30.
Structural allografts and PEEK cages are commonly used interbody fusion devices in ACDF. The subsidence rates of these two spacers have not yet been directly compared. The primary aim of this study was to compare the subsidence rate of allograft and PEEK cage in ACDF. The secondary aim was to determine if the presence of subsidence affects the clinical outcome. We reviewed 67 cases (117 levels) of ACDF with either structural allograft or PEEK cages. There were 85 levels (48 cases) with PEEK and 32 levels (19 cases) with allograft spacers. Anterior and posterior disc heights at each operative level were measured at immediate and 6months post-op. Subsidence was defined as a decrease in anterior or posterior disc heights >2mm. NDI of the subsidence (SG) and non-subsidence group (NSG) were recorded. Chi-square test was used to analyze subsidence rates. T-test was used to analyze clinical outcomes (α=0.05). There was no statistically significant difference between subsidence rates of the PEEK (29%; 25/85) and allograft group (28%; 9/32) (p=0.69). Overall mean subsidence was 2.3±1.7mm anteriorly and 2.6±1.2mm posteriorly. Mean NDI improvement was 11.7 (from 47.1 to 35.4; average follow-up: 12mos) for the SG and 14.0 (from 45.8 to 31.8; average follow-up: 13mos) for the NSG (p=0.74). Subsidence rate does not seem to be affected by the use of either PEEK or allograft as spacers in ACDF. Furthermore, subsidence alone does not seem to be predictive of clinical outcomes of ACDF.
结构性同种异体骨移植和聚醚醚酮(PEEK)椎间融合器是颈椎前路椎间盘切除融合术(ACDF)中常用的椎间融合装置。这两种椎间融合器的下沉率尚未直接比较。本研究的主要目的是比较ACDF中同种异体骨移植和PEEK椎间融合器的下沉率。次要目的是确定下沉的存在是否会影响临床结果。我们回顾了67例(117个节段)采用结构性同种异体骨移植或PEEK椎间融合器的ACDF病例。其中有85个节段(48例)使用PEEK,32个节段(19例)使用同种异体骨移植椎间融合器。在手术即刻和术后6个月测量每个手术节段的前后椎间盘高度。下沉定义为前后椎间盘高度下降>2mm。记录下沉组(SG)和无下沉组(NSG)的颈椎功能障碍指数(NDI)。采用卡方检验分析下沉率。采用t检验分析临床结果(α=0.05)。PEEK组(29%;25/85)和同种异体骨移植组(28%;9/32)的下沉率之间无统计学显著差异(p=0.69)。总体平均下沉在前为2.3±1.7mm,在后为2.6±1.2mm。SG组的平均NDI改善为11.7(从47.1降至35.4;平均随访:12个月),NSG组为14.0(从45.8降至31.8;平均随访:13个月)(p=0.74)。在ACDF中,下沉率似乎不受使用PEEK或同种异体骨移植作为椎间融合器的影响。此外,仅下沉似乎不能预测ACDF的临床结果。
BMC Musculoskelet Disord. 2012-9-14
BMC Musculoskelet Disord. 2025-7-4
Rev Med Inst Mex Seguro Soc. 2023-9-18